DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02185 BIOHEART-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Philip Li WANG & Associates (43.75%)
Peili Wang (10.41%)
Yang Xu & Associates (6.85%)
TPG Inc. (5.78%)
Magic Grace Limited (5.01%)		 Sector Health Care & Biotechnology
Web Site http://www.bio-heart.com Tel (86 21) 5072-2068
Email info@bio-heart.com Fax (86 21) 6879-8512
Related Equities N/A
Principal Activities Principally engaged in the research and development of bioresorbable scaffold (“BRS”) products and the second-generation renal denervation (“RDN”) system.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top